←
Dr. Jason Efstathiou236 posts
Dr. Jason Efstathiou avatar✓

Dr. Jason Efstathiou ✓

@drjefstathiou

Prof. of Radiation Oncology @HarvardMed Vice Chair, Faculty Enrichment & Program Director, Genitourinary Radiation Oncology @MassGenBrigham Cancer Inst.

◷ Joined September 2024▧ 103 Photos and videos
Advanced Prostate Cancer Consensus Conference avatar
⟳ Dr. Jason Efstathiou retweeted
Advanced Prostate Cancer Consensus Conference@APCCC_Lugano·Nov 8

Prof. Lisa Horvath, Prof Noel Clarke and Prof. Anthony Joshua Discuss The Role of Status in #ProstateCancer Discussion captured from the LIVE from Lugano🇨🇭 Series during APCCC 2026 in collaboration with @OncoAlert 🚨 youtu.be/o2iv9WQpZLc 🎓 Series Faculty @APCCC_Lugano · @BertrandTOMBAL · @ChrisSweens1 · @jmmrad · @drjefstathiou · @CaPsurvivorship · @LoebStacy · @charlesryanmd · @AarmstrongDuke · @Ecastromarcos · @LVM_Walz · @piet_ost · @Nicola_Fossati · @AnthonyMJoshua · @Prof_Nick_James · @VedangMurthy · @AttardLab · @Silke_Gillessen · @AOmlin · @ProfKHerrmann 📣 Also tagging @gu_onc · @tompowles1 · @brian_rini · @declangmurphy · @cdanicas · @neerajaiims · @mzugman · @AmandaNizamMD · @scocmem · @nataliagandur

Speed of Light - The ASTRO Foundation avatar
⟳ Dr. Jason Efstathiou retweeted
Speed of Light - The ASTRO Foundation@SpeedofLightFdn·Nov 6

Apply now for the 2027 ACS-ASTRO Dr. Felix Feng Clinician Scientist Development Grant (CSDG) Supporting practicing radiation oncologists pursuing research questions relevant to improving health across the cancer continuum. In honor of Felix Feng, MD. @AmericanCancer @ASTRO_org Award Amount: Up to $729,000 Award Duration: 3-5 years Applications Due December 1, 2026. Learn more: bit.ly/4zBFLxe @MaryFengMD

Post attachment
Dr. Jason Efstathiou avatar
Dr. Jason Efstathiou@drjefstathiou·Nov 6

Thank you to @UrologyUS for a terrific 18th Annual Meeting in Chicago! 🙏 I enjoyed presenting on modern strategies for metastasis-directed therapy (MDT) in APMN/S and APMR metastatic prostate cancer. 🔑 Key takeaways: • MDT’s role extends beyond delaying ADT: it should be coordinated with systemic therapy and treatment of the primary when indicated. • Treating all sites of limited disease and targeting isolated progression are distinct strategies with different goals. • Ongoing phase III trials are testing MDT’s impact on survival, progression, and quality of life alongside modern systemic therapy. • The next challenges: identifying who benefits most, how many lesions to treat, when to repeat MDT, and whether systemic therapy can safely be shortened or paused. Great discussions with colleagues advancing prostate cancer care! @HafronJason #LUGPA2026 #ProstateCancer #RadiationOncology #Urology

Post attachment
Speed of Light - The ASTRO Foundation avatar
⟳ Dr. Jason Efstathiou retweeted
Speed of Light - The ASTRO Foundation@SpeedofLightFdn·Oct 13

Call for volunteers: Speed of Light – The ASTRO Foundation committees & subcommittees! Want to get involved in the ASTRO Foundation? This could be you! Speed of Light – The ASTRO Foundation is now accepting volunteers to serve on committees and subcommittees for the Society year beginning Jan. 1, 2027. Submit your preferences by Oct. 16: bit.ly/3TwbtMq

Post attachment
Dr. Jason Efstathiou avatar
Dr. Jason Efstathiou@drjefstathiou·Sep 30

Last night's ASTRO Gold Medal Gala brought together guests to honor the 2026 Gold Medal Recipients and recipients of the new Corporate Partner Award. The event also featured silent and live fundraising auctions, all proceeds directly benefiting the goals of @SpeedofLightFdn: 🔬Accelerating research in strategic areas 🥼Enabling early-career investigators 🏥Expanding patient access to cancer and survivorship resources It's always empowering to see friends and colleagues come together to support each other and ASTRO’s mission! @ASTRO_org @MassGenBrigham #ASTRO26 #RadiationOncology #ASTROFoundation #Boston

Post attachment
José Máximo Barros, MD 🇦🇷 avatar
⟳ Dr. Jason Efstathiou retweeted
José Máximo Barros, MD 🇦🇷@barrosonco·Sep 28

#BladderCancer #TMT #ASTRO26 @ASTRO_org Guidelines by @drjefstathiou and team Key message Radiotherapy is a critical component of bladder cancer care. For selected patients with MIBC (cT2–4aN0M0), trimodality therapy is a guideline-supported alternative to radical cystectomy — combining maximal TURBT, concurrent radiosensitization and RT. 🎯 Bladder preservation is not a compromise. It is an evidence-based treatment strategy.

Dr. Jason Efstathiou avatar
Dr. Jason Efstathiou@drjefstathiou·Sep 25

🔬Always a highlight of the year, the @ASTRO_org Annual Meeting, is taking place here in Boston September 26–30! ASTRO brings together top minds from across the field to explore the latest science shaping radiation oncology, exchange ideas, and reconnect as a community. This year also marks an exciting new chapter for the ASTRO Foundation with Speed of Light, its renewed identity inspired by the transformative impact of radiation and a shared commitment to advancing research and education. Culminating with this year's Gala to support the ASTRO Foundation and its critical work🌟 Here’s to a great week of science, collaboration, and community. See you in Boston! @SpeedofLightFdn @MassGenBrigham #ASTRO26 #RadiationOncology #ASTROFoundation #Boston

Post attachment